Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity

• Egile Nagusiak: Marleen E. Jansen (Egilea), T. Rigter (Egilea), W. Rodenburg (Egilea), T. M. C. Fleur (Egilea), E. J. F. Houwink (Egilea), M. Weda (Egilea), Martina C. Cornel (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2017-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Advances from pharmacogenetics (PGx) have not been implemented into health care to the expected extent. One gap that will be addressed in this study is a lack of reporting on clinical validity and clinical utility of PGx-tests. A systematic review of current reporting in scientific literature was co...